OTC · Financial Statements

Actavia Life Sciences, Inc. (RASP) Financial Statements

$0.00 OTC: RASP Market Cap $385906

Actavia Life Sciences, Inc. most recently reported annual revenue of $0, a net loss of $4.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20192020202120222023
Revenue$0$0$0$0$0
Operating Profit$-1.0M$-5.0M$0$0$-4.0M
Net Profit$-1.0M$-5.0M$-1.0M$-1.0M$-4.0M
EPS$-0.01$-0.08$-0.01$-0.01$-0.01
Op Margin—————

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$5.0M$0$0$0$0
Total Liabilities$2.0M$3.0M$3.0M$2.0M$2.0M
Cash$0$0$0$0$0
Borrowings$0$1.0M$1.0M$0$0

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$0$0$0$0$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-1.37
FCF Yield-2.21%
Quick Ratio0.06
Interest Coverage-19.90
Return 1Y-87.50%
Return 3Y-97.78%
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
RASP Overview RASP Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.